September 18,2013 | By Márcio Barra
The President of the Portuguese Association of Pharmaceutical Industries (APIFARMA), João Almeida Lopes, revealed today that the public expenditure on medicines compared to the Gross Domestic Product (GDP) will reach 1.13% this year, higher than the 1% target set by Troika. This was disclosed on a conference organized by APIFARMA on “biopharmaceutical and biosimilars innovation”, where João Almeida Lopes told the reporters that the goal of one percent of GDP set by the government under the ongoing economic program is ‘unattainable’.
“That value is not attainable and will not be achieved. There are values that are not feasible. In spreadsheets everything fits, but then the reality is something else”. “It is a goal decontextualized from reality,” he stressed, adding that this was initially only be for the outpatient market and only later was it imposed for hospital expenditure with medicines.
João Almeida Lopes estimates that this year public expenditure on medicines should reach 1.13% of GDP, missing the target by 0.13%, a value that is still “in line with the European targets”. The values for the 2013 agreement between the Ministries of Health, Economy, Employment, Finances and the Pharmaceutical Industry for the sustainability of the National Health Service are still being discussed at the moment. A similar deal was signed in 2012, were pharmaceutical companies agreed to cooperate in reducing drug expenditure by 300 million euros compared to 2011, through cuts of 170 million euros in public expenditure of the hospital market and 130 million euros in the outpatient market.